Standout Papers

A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease 2017 2026 2020 2023 403
  1. A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease (2017)
    Susanne Ostrowitzki, Robert Lasser et al. Alzheimer s Research & Therapy

Immediate Impact

1 by Nobel laureates 13 from Science/Nature 58 standout
Sub-graph 1 of 19

Citing Papers

A natural experiment on the effect of herpes zoster vaccination on dementia
2025 StandoutNature
Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease
2025 StandoutNature
2 intermediate papers

Works of Ernest Dorflinger being referenced

A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
2017 Standout
Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter‐ and intrarater reliability assessment
1994

Author Peers

Author Last Decade Papers Cites
Ernest Dorflinger 866 383 383 384 18 1.7k
Christopher van Dyck 554 347 435 575 25 1.8k
Martin Koller 394 333 247 672 22 1.3k
Robert Perry 367 429 435 385 19 1.9k
Akihiko Koyama 607 284 460 1007 24 1.7k
Gabriel C. Léger 470 510 354 516 43 1.9k
Katrina L. Paumier 918 325 631 714 26 1.8k
Laëtitia Lemoine 272 407 330 853 31 1.5k
Zsolt Cselényi 321 353 437 529 56 1.7k
Marta Marquié 763 623 289 1084 38 1.8k
Susanne Ostrowitzki 456 314 343 965 41 2.1k

All Works

Loading papers...

Rankless by CCL
2026